Exercise for Patients With Renal Cell Cancer Receiving Sunitinib
In this randomized, controlled trial the investigators evaluate the effects of an exercise program lasting for 12 weeks on the physical performance, the cardiovascular function (24h blood pressure, rest blood pressure and hear function) and the fatigue and mood of patients with renal cell carcinoma undergoing a therapy with Sunitinib.
Renal Cell Carcinoma
OTHER: Endurance exercise
Fatigue, 12 weeks
VO2max, 12 weeks|Systolic and diastolic blood pressure (24 h), 12 weeks|Depression score, 12 weeks
In this randomized, controlled trial the investigators evaluate the effects of an exercise program lasting for 12 weeks on the physical performance, the cardiovascular function (24h blood pressure, rest blood pressure and hear function) and the fatigue and mood of patients with renal cell carcinoma undergoing a therapy with Sunitinib.